4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-14-072887
CIK 0001411158operating
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:09 PM ET
Size
7.3 KB
Accession
0001209191-14-072887
Insider Transaction Report
Form 4
Plattner Jacob j
Senior VP Research
Transactions
- Sale
Common Stock
2014-12-01$34.08/sh−900$30,672→ 65,225 total(indirect: See Footnote) - Sale
Common Stock
2014-12-01$33.23/sh−5,975$198,565→ 66,125 total(indirect: See Footnote)
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2014.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.82, inclusive.
- [F3]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.
- [F4]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $33.97 to $34.16, inclusive.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 7:09 PM ET
- Size
- 7.3 KB